Difference between revisions of "Part:BBa I751501"
m (→Usage and Biology) |
m |
||
Line 9: | Line 9: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | The characteristics of this hybrid promoter (Lux-lac hybrid promoter) have been determined though [http://parts.mit.edu/igem07/index.php/Tokyo/Works/Assay0| Assay 0]. The results are shown in Fig. | + | The characteristics of this hybrid promoter (Lux-lac hybrid promoter) have been determined though [http://parts.mit.edu/igem07/index.php/Tokyo/Works/Assay0| Assay 0]. The results are shown in Fig.1. |
'''The newly devised hybrid promoter is activated by AHL and repressed by LacI.''' | '''The newly devised hybrid promoter is activated by AHL and repressed by LacI.''' | ||
<br>In the present project, this hybrid promoter has been tested on the [[Part:BBa_I751100|BBa_I751100. (J54140del Pr)]] | <br>In the present project, this hybrid promoter has been tested on the [[Part:BBa_I751100|BBa_I751100. (J54140del Pr)]] | ||
− | [[Image : Hybridgraph.JPG|thumb|300px| '''Fig. | + | [[Image : Hybridgraph.JPG|thumb|300px| '''Fig.1: The result of assay0''' <br>Only in the presence of AHL and in the absence of lacI, the lux lac hybrid promoter is activated significantly.|right]] |
+ | <br><br><br> | ||
<br> | <br> | ||
+ | <br><br> | ||
+ | <br> | ||
+ | <br><br> | ||
+ | <br> | ||
+ | |||
+ | |||
+ | |||
===Functional Parameters=== | ===Functional Parameters=== | ||
<partinfo>BBa_I751501 parameters</partinfo> | <partinfo>BBa_I751501 parameters</partinfo> | ||
== [[Tokyo/AHL assay|1.AHL assay]] == | == [[Tokyo/AHL assay|1.AHL assay]] == | ||
− | <br>[[Image:hill AHL.JPG|thumb|210px|'''Fig. | + | <br>[[Image:hill AHL.JPG|thumb|210px|'''Fig.2 The result of AHL assay''' Fluorescence intensity (arbitrary unit, a.u.) as a function of the concentration of AHL was determined. ]] |
'''Purpose''' | '''Purpose''' | ||
<br>check how AHL activates lux-lac hybrid promoter. | <br>check how AHL activates lux-lac hybrid promoter. | ||
Line 26: | Line 34: | ||
'''Result & Conclusion''' | '''Result & Conclusion''' | ||
− | <br>As the concentration of AHL increases, GFP fluorescence increased, indicating that the hybrid promoter’s activation is strengthend with increasing concentration of AHL. From the activation graph in Fig. | + | <br>As the concentration of AHL increases, GFP fluorescence increased, indicating that the hybrid promoter’s activation is strengthend with increasing concentration of AHL. From the activation graph in Fig. 2, the characteristics of the hybrid promoter expressed in Hill function, such as (n2,K2), is determined. |
<br> | <br> | ||
− | ====⇒see more [http://parts.mit.edu/igem07/index.php/Tokyo/AHL_assay|details]==== | + | ====⇒see more [http://parts.mit.edu/igem07/index.php/Tokyo/AHL_assay| details]==== |
== [[Tokyo/IPTG assay|2.IPTG assay]] == | == [[Tokyo/IPTG assay|2.IPTG assay]] == | ||
− | [[Image:hill IPTG.JPG|thumb|210px|'''Fig. | + | [[Image:hill IPTG.JPG|thumb|210px|'''Fig.3 The result of IPTG assay''' Fluorescence intensity as a function of the concentration of IPTG was determined. ]] |
'''Purpose''' | '''Purpose''' | ||
− | <br>check how LacI represses this hybrid promoter. In order to adjust LacI repression | + | <br>check how LacI represses this hybrid promoter. In order to adjust LacI repression, IPTG was added. |
<br>These parameters(n3,K3) is decided. | <br>These parameters(n3,K3) is decided. | ||
− | + | ||
− | + | ||
− | + | ||
'''Result & Conclusion''' | '''Result & Conclusion''' | ||
− | |||
− | |||
<br> | <br> | ||
− | ====⇒see more [http://parts.mit.edu/igem07/index.php/Tokyo/IPTG_assay|details]==== | + | The concentration of IPTG dose-denpendently increased GFP fluorescence. It indicates that the hybrid promoter in the cells expressing LacI became increasingly strengthened by decline of repression by LacI. The activation graph in Fig. 3, the characteristics of the hybrid promoter expressed in Hill function is determined. |
+ | <br> | ||
+ | ====⇒see more [http://parts.mit.edu/igem07/index.php/Tokyo/IPTG_assay| details]==== | ||
<!-- --> | <!-- --> |
Revision as of 17:05, 26 October 2007
plux-cI hybrid promoter
sense TWO INPUTS, activation by AHL and repression by Lambda cI.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Usage and Biology
The characteristics of this hybrid promoter (Lux-lac hybrid promoter) have been determined though [http://parts.mit.edu/igem07/index.php/Tokyo/Works/Assay0| Assay 0]. The results are shown in Fig.1.
The newly devised hybrid promoter is activated by AHL and repressed by LacI.
In the present project, this hybrid promoter has been tested on the BBa_I751100. (J54140del Pr)
Functional Parameters
negative_regulators | 1 |
positive_regulators | 1 |
1.AHL assay
Purpose
check how AHL activates lux-lac hybrid promoter.
These parameters(n2,K2) is decided.
Result & Conclusion
As the concentration of AHL increases, GFP fluorescence increased, indicating that the hybrid promoter’s activation is strengthend with increasing concentration of AHL. From the activation graph in Fig. 2, the characteristics of the hybrid promoter expressed in Hill function, such as (n2,K2), is determined.
⇒see more [http://parts.mit.edu/igem07/index.php/Tokyo/AHL_assay| details]
2.IPTG assay
Purpose
check how LacI represses this hybrid promoter. In order to adjust LacI repression, IPTG was added.
These parameters(n3,K3) is decided.
Result & Conclusion
The concentration of IPTG dose-denpendently increased GFP fluorescence. It indicates that the hybrid promoter in the cells expressing LacI became increasingly strengthened by decline of repression by LacI. The activation graph in Fig. 3, the characteristics of the hybrid promoter expressed in Hill function is determined.